Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25366685

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Jan 20
First author
Kaufman B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Jan 20;33(3):229-31. doi: 10.1200/JCO.2014.59.2311.
    note
    Source null
    related pmid
    25452438
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2015 Aug 10;33(23):2581-2. doi: 10.1200/JCO.2014.60.0585.
    note
    Source null
    related pmid
    26124473
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2015 Aug 10;33(23):2582. doi: 10.1200/JCO.2015.61.0576.
    note
    Source null
    related pmid
    26124479
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2015 Aug 10;33(23):2583-4. doi: 10.1200/JCO.2015.61.8298.
    note
    Source null
    related pmid
    26124483
    relationship
    Comment in
  5. citation
    Bull Cancer. 2019 Sep;106(9):717-718. doi: 10.1016/j.bulcan.2019.07.003.
    note
    Source null
    related pmid
    31420091
    relationship
    Comment in

Authors and identifiers

  1. name
    Kaufman B
    type
    Author
  2. name
    Shapira-Frommer R
    type
    Author
  3. name
    Schmutzler RK
    type
    Author
  4. name
    Audeh MW
    type
    Author
  5. name
    Friedlander M
    type
    Author
  6. name
    Balmaña J
    type
    Author
  7. name
    Mitchell G
    type
    Author
  8. name
    Fried G
    type
    Author
  9. name
    Stemmer SM
    type
    Author
  10. name
    Hubert A
    type
    Author
  11. name
    Rosengarten O
    type
    Author
  12. name
    Steiner M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kaufman B
    type
    Author
  2. name
    Shapira-Frommer R
    type
    Author
  3. name
    Schmutzler RK
    type
    Author
  4. name
    Audeh MW
    type
    Author
  5. name
    Friedlander M
    type
    Author
  6. name
    Balmaña J
    type
    Author
  7. name
    Mitchell G
    type
    Author
  8. name
    Fried G
    type
    Author
  9. name
    Stemmer SM
    type
    Author
  10. name
    Hubert A
    type
    Author
  11. name
    Rosengarten O
    type
    Author
  12. name
    Steiner M
    type
    Author
bibliography ids
  1. nci-bib-03c6bda0b092c181ebbcd7dd
book metadata
content sha256
f86978b2c9c7696d42a9aa5f2820275962fb3b6803fac865eb4f645cbe3fe5bf
document type
citation
dois
  1. 10.1200/JCO.2014.56.2728
electronic publication date
display
2014 Nov 3
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:25366685
immutable id
pubmed:25366685@f86978b2c9c7696d42a9aa5f2820275962fb3b6803fac865eb4f645cbe3fe5bf
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
3
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
244-50
volume
33
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Jan 20;33(3):229-31. doi: 10.1200/JCO.2014.59.2311.
    note
    Source null
    related pmid
    25452438
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2015 Aug 10;33(23):2581-2. doi: 10.1200/JCO.2014.60.0585.
    note
    Source null
    related pmid
    26124473
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2015 Aug 10;33(23):2582. doi: 10.1200/JCO.2015.61.0576.
    note
    Source null
    related pmid
    26124479
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2015 Aug 10;33(23):2583-4. doi: 10.1200/JCO.2015.61.8298.
    note
    Source null
    related pmid
    26124483
    relationship
    Comment in
  5. citation
    Bull Cancer. 2019 Sep;106(9):717-718. doi: 10.1016/j.bulcan.2019.07.003.
    note
    Source null
    related pmid
    31420091
    relationship
    Comment in
outcomes validated
false
pmid
25366685
provenance
batch id
863b068fe5a07222af6a
provider
NCBI PubMed ESummary
record sha256
9f87967e6ff745b5d907a33d63dbdb190bb15125ba422538ddfb307442af6908
response sha256
80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
retrieved at
2026-09-09T23:47:07.648963+00:00
publication date
display
2015 Jan 20
precision
day
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25366685/
title
Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

Preserved source evidence · Not medical advice